VC-backed PMV Pharmaceuticals adds to board of directors
PMV Pharmaceuticals, which is backed by InterWest Partners, has appointed Steven Holtzman to its board of directors. Currently, Holtzman is the executive vice president of corporate development for Biogen Idec. PMV Pharmaceuticals is focused on developing first-in-class p53 and p53 pathway modulators that treat cancer and infectious disease.
30 April 2014•3 mins read
